Exactly How Much Omega-3 Is in There?

On April 28, 2014, the Food and Drug Administration (FDA) issued a Final Rule prohibiting certain "nutrient content claims" for docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha-linolenic acid (ALA) omega-3 fatty acids. Although the nutrient content claims for DHA, EPA and the ALA based on the population-weighted approach were rejected, FDA stated that no regulatory action would be taken against nutrient content claims for ALA based on the population-coverage adequate-intake (AI) level.

It is uncertain whether these actions will protect the public health. Indeed, the complexities associated with developing reference values for nutrients based on Reference Daily Intakes (RDIs) or Daily Reference Values (DRVs) raise issues as to whether consumers understand the meaning of nutrient content claims such as "good source" or "high in." Moreover, it appears that First Amendment issues may be raised under this Final Rule considering commercial speech may have been unnecessarily limited merely because such nutrient content claims rely on more than one method of assessing a nutrient level.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Dietary Supplements, FDA, Final Rules, Food Labeling

Published In: Administrative Agency Updates, Communications & Media Updates, Constitutional Law Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Venable LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »